Mp07-02 baseline body mass index and estradiol levels predict combination therapy with anastrozole in hypogonadal men treated with clomiphene citrate
Clomiphene citrate (CC) is commonly used in the treatment of male hypogonadism/infertility as an off-label medication. CC can cause increased estradiol (E) levels and decreased testosterone to estradiol ratio (T/E) in some patients necessitating addition of aromatase inhibitors such as Anastrozole (AZ) to optimize E and T/E levels. Little data is available on the conversion rate from CC monotherapy to combination CC+AZ therapy and the predictors of this conversion.
Source: The Journal of Urology - Category: Urology & Nephrology Authors: Sorena Keihani, Rachel Moses, Jeremy Myers, James Hotaling Tags: Infertility: Therapy II Source Type: research
More News: Arimidex | Clomid | Estradiol | Infertility | Low Testosterone | Reproduction Medicine | Urology & Nephrology